C.B. Fleet Amends Senior Credit Facility
TM Capital advised C.B. Fleet in completing an amended senior credit facility
TM Capital advised C.B. Fleet in completing an amended senior credit facility
TM Capital advised CorVista Health, Inc. in raising $65 million of Series C equity capital to advance its artificial intelligence-based cardiovascular diagnostic technology
TM Capital completed the sale of SteriGenics International, Inc. (NASDAQ) to Ion Beam Applications s.a. of Belgium for $214 million in cash
TM Capital served as exclusive financial advisor to founder-owned Time-Cap Labs, Inc. in its sale to Marksans Pharma Limited (BSE:524404), headquartered in Mumbai, India
TM Capital, together with Pegasus Capital, served as a financial advisor to Empirical Bioscience in its sale to Fortis Life Sciences